Vitamin K, circulating cytokines, and bone mineral density

1 post / 0 new
stargazer
Vitamin K, circulating cytokines, and bone mineral density

Shea MK, Dallal GE, Dawson-Hughes B, et al. Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr 2008 Aug;88(2):356-363.

http://www.ajcn.org/cgi/content/abstract/88/2/356
http://www.ajcn.org/cgi/content/full/88/2/356
http://www.ajcn.org/cgi/reprint/88/2/356

++++++++

American Journal of Clinical Nutrition, Vol. 88, No. 2, 356-363, August 2008
© 2008 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION
Vitamin K, circulating cytokines, and bone mineral density in older men and women1,2,3,4
M Kyla Shea, Gerard E Dallal, Bess Dawson-Hughes, José M Ordovas, Christopher J O'Donnell, Caren M Gundberg, James W Peterson and Sarah L Booth
1 From the US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA (MKS, GED, BD-H, JMO, JWP, and SLB); the NIH National Heart, Lung, and Blood Institute, Framingham Heart Study, Framingham, MA (CJO); and the Department of Orthopaedics, Yale University School of Medicine, New Haven, CT (CMG)

Background: Vitamin K modulates cytokines involved in bone turnover, including interleukin-6 (IL-6) and osteoprotegerin in vitro.
Objective: The objective of this study was to assess 1) associations between measures of vitamin K status [plasma phylloquinone and serum percentage of undercarboxylated osteocalcin (%ucOC)] and IL-6, osteoprotegerin, and C-reactive protein (CRP) concentrations and 2) the effect of daily 500 µg phylloquinone supplementation for 3 y on cytokine concentrations.
Design: Concentrations of IL-6, osteoprotegerin, and CRP and bone mineral density (BMD) were measured at baseline and after 3 y of follow-up in 379 healthy men and women (60–81 y; 58.5% women) participating in a randomized trial that studied the effect of vitamin K supplementation on bone loss.
Results: Cross-sectionally, plasma phylloquinone was inversely associated with IL-6 and CRP, whereas serum %ucOC was inversely associated with IL-6. Osteoprotegerin was associated positively with plasma phylloquinone and inversely with %ucOC. No differences were observed in the 3-y change in IL-6, osteoprotegerin, and CRP concentrations between participants who received phylloquinone supplementation and those who did not. Overall, no association was observed between the 3-y changes in circulating cytokines and BMD.
Conclusions: Poor vitamin K status was associated with high concentrations of cytokines involved in bone turnover, but vitamin K supplementation did not confer a decrease in cytokine concentrations. The healthy status of this cohort may explain a lack of effect of vitamin K supplementation on cytokine concentrations. This trial was registered with www.clinicaltrials.gov as NCT00183001.

Copyright © 2008 by The American Society for Nutrition